+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Stability of compounded thioguanine oral suspensions



Stability of compounded thioguanine oral suspensions



American Journal of Health-System Pharmacy 68(10): 900-908



PURPOSE. Updated information on the stability of compounded thioguanine oral suspensions prepared with currently available ingredients, as well as results of testing to determine if the addition of an antioxidant could extend shelf life by inhibiting formation of guanine, are presented. METHODS. Using triturated thioguanine tablets, three compounded suspensions were prepared: (1) a reference formulation containing methylcellulose and simple syrup, (2) an equivalent formulation using Ora-Plus and Ora-Sweet, and (3) an antioxidant-containing formulation prepared by adding ascorbic acid to the equivalent formulation. The compounded batches were stored at room temperature (19-23 °C). The chemical stability of the suspensions was evaluated immediately after compounding and at weekly intervals by a validated liquid chromatography-mass spectrometry (LCMS) assay method; physical stability was evaluated by regular visual checks and weekly pH testing. RESULTS. As demonstrated by serial LCMS testing, mean thioguanine levels in sampled batches of all three suspensions remained above accepted standards and mean guanine formation remained within acceptable limits for up to 63 days. The addition of ascorbic acid appeared to slow guanine formation but did not significantly extend the shelf life of the suspension. CONCLUSION. Compounded oral suspensions of thioguanine 20 mg/mL exhibited acceptable chemical and physical stability for up to nine weeks at 19-23 °C. The addition of ascorbic acid at a concentration of 0.1% to the suspension was not effective in consistently increasing the shelf life of the thioguanine suspensions.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055898046

Download citation: RISBibTeXText

PMID: 21546641

DOI: 10.2146/ajhp100163


Related references

Stability of Dapsone in Extemporaneously Compounded Oral Suspensions. Canadian Journal of Hospital Pharmacy 71(2): 152-154, 2018

Temozolomide stability in extemporaneously compounded oral suspensions. International Journal of Pharmaceutical Compounding 10(5): 396-399, 2006

Stability of zonisamide in extemporaneously compounded oral suspensions. American Journal of Health-System Pharmacy 66(12): 1105-1109, 2009

Stability of gabapentin in extemporaneously compounded oral suspensions. Plos One 12(4): E0175208-E0175208, 2017

Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions. Plos One 11(10): E0164577-E0164577, 2016

Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions. Canadian Journal of Hospital Pharmacy 69(4): 327-329, 2016

Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals. Journal of the American Veterinary Medical Association 243(1): 85-90, 2014

Stability of propranolol in extemporaneously compounded suspensions. Canadian Journal of Hospital Pharmacy 66(2): 118-124, 2013

Stability of levetiracetam in extemporaneously compounded suspensions. Canadian Journal of Hospital Pharmacy 64(3): 207-211, 2012

Stability of extemporaneously compounded spironolactone suspensions. American Journal of Hospital Pharmacy 46(10): 2040-2042, 1989

Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. International Journal of Pharmaceutical Compounding 23(1): 70-76, 2019

Naratriptan hydrochloride in extemporaneosly compounded oral suspensions. International Journal of Pharmaceutical Compounding 4(1): 69-71, 2000

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children. International Journal of Pharmaceutical Compounding 20(3): 257-261, 2016

The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions. International Journal of Pharmaceutical Compounding 22(2): 164-171, 2018

Quality assessment of fluconazole capsules and oral suspensions compounded by pharmacies located in the United States. American Journal of Veterinary Research 78(4): 421-432, 2017